308 related articles for article (PubMed ID: 30723918)
21. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
22. microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4.
He L; Meng D; Zhang SH; Zhang Y; Deng Z; Kong LB
Biochem Biophys Res Commun; 2018 Jul; 501(4):1060-1067. PubMed ID: 29777702
[TBL] [Abstract][Full Text] [Related]
23. Oncogene-dependent function of BRG1 in hepatocarcinogenesis.
Wang P; Song X; Cao D; Cui K; Wang J; Utpatel K; Shang R; Wang H; Che L; Evert M; Zhao K; Calvisi DF; Chen X
Cell Death Dis; 2020 Feb; 11(2):91. PubMed ID: 32019910
[TBL] [Abstract][Full Text] [Related]
24. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
25. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
26. c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma.
Wang L; Zhang X; Jia LT; Hu SJ; Zhao J; Yang JD; Wen WH; Wang Z; Wang T; Zhao J; Wang RA; Meng YL; Nie YZ; Dou KF; Chen SY; Yao LB; Fan DM; Zhang R; Yang AG
Hepatology; 2014 May; 59(5):1850-63. PubMed ID: 24002871
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
28. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
29. The transcription factor FOXN3 inhibits cell proliferation by downregulating E2F5 expression in hepatocellular carcinoma cells.
Sun J; Li H; Huo Q; Cui M; Ge C; Zhao F; Tian H; Chen T; Yao M; Li J
Oncotarget; 2016 Jul; 7(28):43534-43545. PubMed ID: 27259277
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
He F; Li J; Xu J; Zhang S; Xu Y; Zhao W; Yin Z; Wang X
J Exp Clin Cancer Res; 2015 May; 34(1):47. PubMed ID: 25975202
[TBL] [Abstract][Full Text] [Related]
31. Involvement of MAFB and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion.
Tsuchiya H; Oura S
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757260
[TBL] [Abstract][Full Text] [Related]
32. ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma.
Zhang L; Huo Q; Ge C; Zhao F; Zhou Q; Chen X; Tian H; Chen T; Xie H; Cui Y; Yao M; Li H; Li J
Cancer Res; 2020 Jun; 80(12):2599-2611. PubMed ID: 32312832
[TBL] [Abstract][Full Text] [Related]
33. Targeting complexes of super-enhancers is a promising strategy for cancer therapy.
Zheng C; Liu M; Fan H
Oncol Lett; 2020 Sep; 20(3):2557-2566. PubMed ID: 32782573
[TBL] [Abstract][Full Text] [Related]
34. FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC.
Kim KM; Park SH; Bae JS; Noh SJ; Tao GZ; Kim JR; Kwon KS; Park HS; Park BH; Lee H; Chung MJ; Moon WS; Sylvester KG; Jang KY
Sci Rep; 2017 Jun; 7(1):3274. PubMed ID: 28607447
[TBL] [Abstract][Full Text] [Related]
35. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
36. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
37. Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin.
Meng J; Han J; Wang X; Wu T; Zhang H; An H; Qin L; Sun Y; Zhong W; Yang C; Liu H; Sun T
Pharmacol Res; 2023 Feb; 188():106661. PubMed ID: 36669583
[TBL] [Abstract][Full Text] [Related]
38. CDK7 blockade suppresses super-enhancer-associated oncogenes in bladder cancer.
Yang Y; Jiang D; Zhou Z; Xiong H; Yang X; Peng G; Xia W; Wang S; Lei H; Zhao J; Qian Z; Wu S; Pang J
Cell Oncol (Dordr); 2021 Aug; 44(4):871-887. PubMed ID: 33905040
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
40. The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma.
Zhao J; Chen J; Lin H; Jin R; Liu J; Liu X; Meng N; Cai X
Pathol Oncol Res; 2016 Jul; 22(3):453-9. PubMed ID: 26589513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]